• Persistent fatigue: long-lasting tiredness or low stamina that may relate to immune activity.
• Recurrent sore throat or gland discomfort: ongoing throat irritation or enlarged lymph nodes under practitioner review.
• Viral-pattern symptoms: episodes resembling flu-like illness, low-grade malaise or post-viral presentations.
• Mood or cognitive changes: brain fog, reduced mental clarity or fluctuating mood potentially linked with immune response patterns.
• Neurological concerns: ataxia, neuropathic sensations or other neurological symptoms monitored by a practitioner.
• Autoimmune tendencies: clients with confirmed or suspected autoimmune conditions under practitioner care.
• Chronic inflammatory patterns: long-term inflammation or symptoms suggesting ongoing immune activation.
• Previous Epstein-Barr virus infection: history of infectious mononucleosis or suspected EBV reactivation.
• Complex multi-infection context: clients with exposure history or symptoms prompting exploration of additional immune challenges.
• Immune function considerations: clients with unexplained immune fluctuations or those not producing typical antibody responses.

Overview

The Epstein-Barr Virus Elispot test measures T-cell reactivity to EBV lytic antigens, which relate to active viral phases, and latent antigens, which relate to dormant phases, providing a detailed view of current cellular immune response patterns. The analysis offers insight into how the immune system is responding to different stages of EBV exposure based on T-cell activity.

Clinically, this assessment may be relevant when exploring long-lasting fatigue, recurrent viral-pattern symptoms, gland discomfort, cognitive or neurological changes, autoimmune tendencies or chronic inflammatory presentations under practitioner review. The differentiation between lytic and latent responses can help contextualise whether cellular activity appears more consistent with active or dormant EBV phases.

Practitioners typically interpret these results alongside health history, antibody testing, symptom timelines, environmental and lifestyle factors and any prior viral exposures. Used within this broader context, the Epstein–Barr Virus Elispot test can support practitioner decision-making and help inform discussions about immune-related patterns for clients.

Practical

3 x CPDA tubes

This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.

(Nordic Laboratories accept no cost or claims related to any phlebotomy services in the event of sample rejection or failure for any reason. By ordering this, or any test, requiring phlebotomy services, you accept any inherent risk and any associated costs.)